Search

Your selection

None

Filter by content type

Filter by content year

News

Vaxart Publishes Positive Data for its Oral Bivalent Norovirus Candidate in Lactating Women and Their Infants

January 15, 2026 - … and the potential for a new approach to confer mucosal anti-norovirus immunity to a vulnerable population SOUTH SAN … and the potential for a new approach to confer mucosal anti-norovirus immunity to a vulnerable population SOUTH SAN … and the potential for a new approach to confer mucosal anti-norovirus immunity to a vulnerable population SOUTH SAN …
News

Vaxart Announces Publication Demonstrating the Immunogenicity and Safety of its First-Generation Oral Pill Norovirus Vaccine Candidate in Elderly Adults

March 5, 2025 - … demonstrating statistically significant increases in serum anti-VP1 IgA compared to the placebo cohort on day 29 and day … in vaccine-induced responses were also observed for serum anti-VP1 IgG in all vaccinated cohorts on day 29 and day 57 … demonstrating statistically significant increases in serum anti-VP1 IgA compared to the placebo cohort on day 29 and day …
News

Vaxart Announces Publication in Vaccines of Preclinical Data Supporting the Potential of its Mucosal Vaccine Technology Platform in Enabling Therapeutic Vaccination for HPV-Related Cervical Dysplasia

August 28, 2024 - … needed to further characterize the immune stimulating and anti-tumor activity of our HPV-vaccine, these initial … compared to control groups. Concurrent administration of anti-PD-1 with vaccination further increased animal survival … needed to further characterize the immune stimulating and anti-tumor activity of our HPV-vaccine, these initial …
News

Vaxart Announces Topline Data from the Phase 2 Challenge Study of its Monovalent Norovirus Vaccine Candidate

September 6, 2023 - … Significant increase in the induction of HBGA blocking anti-bodies in the vaccinated cohort (GMFR 3.23) compared … Significant increase in the induction of HBGA blocking anti-bodies in the vaccinated cohort (GMFR 3.23) compared … Significant increase in the induction of HBGA blocking anti-bodies in the vaccinated cohort (GMFR 3.23) compared …
News

Vaxart Announces Creation of Manufacturing and Quality Advisory Board

September 21, 2021 - … for consolidating all phases of drug development for anti-infective drugs in the U.S. and worldwide. Siporin also … for consolidating all phases of drug development for anti-infective drugs in the U.S. and worldwide. Siporin also … for consolidating all phases of drug development for anti-infective drugs in the U.S. and worldwide. Siporin also …
News

Vaxart Reports Boosting Immune Responses in Subjects Previously Vaccinated by a Vaxart Vaccine

July 29, 2021 - … the viral vector as well as the intended antigens. "Anti-vector antibodies from the injected vaccine immune … the viral vector as well as the intended antigens. "Anti-vector antibodies from the injected vaccine immune … the viral vector as well as the intended antigens. "Anti-vector antibodies from the injected vaccine immune …
News

Vaxart Announces Additional Preclinical COVID-19 Oral Vaccine Data and Publication

January 26, 2021 - … N protein was included because it would generate specific anti-viral T-cell responses against a more conserved protein … N protein was included because it would generate specific anti-viral T-cell responses against a more conserved protein … N protein was included because it would generate specific anti-viral T-cell responses against a more conserved protein …
News

Vaxart Announces First Quarter 2020 Financial Results and Provides Corporate Update

May 12, 2020 - … the Company’s lead vaccine candidates generated robust anti-SARS CoV-2 antibodies in all tested animals after both … the Company’s lead vaccine candidates generated robust anti-SARS CoV-2 antibodies in all tested animals after both … the Company’s lead vaccine candidates generated robust anti-SARS CoV-2 antibodies in all tested animals after both …
News

Vaxart Announces Corporate Update for First Quarter 2020

April 28, 2020 - … announced that its lead vaccine candidates generated anti-SARS CoV-2 antibodies in all tested animals after the … announced that its lead vaccine candidates generated anti-SARS CoV-2 antibodies in all tested animals after the … announced that its lead vaccine candidates generated anti-SARS CoV-2 antibodies in all tested animals after the …
News

Vaxart Announces Positive Pre-Clinical Data for its Oral COVID-19 Vaccine Program

April 21, 2020 - … April 21, 2020 General Lead Vaccine Candidates Generate Anti-SARS CoV-2 Antibodies in All Tested Animals after First … animals that received one of the Vaxart vaccines had IgG anti-SARS CoV-2 antibodies in serum two weeks after the first … Source: Vaxart, Inc. Lead Vaccine Candidates Generate Anti-SARS CoV-2 Antibodies in All Tested Animals after First …
Scroll to Top